Extensive analyses of point mutations, copy number alterations, differential expression, and pathways were performed to identify secondary genetic alterations other than the EWSR1-WT1 fusion and pathways that may contribute to DSRCT progression. This evidence concerns the gene EWSR1 and desmoplastic small round cell tumor.